| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |